Sermorelin, 2mg

$25.95 – $233.95

🚚 Free shipping on all orders over $100 (US) and $300 (International)

🔄 7-Days Return Policy

Guaranteed Safe Checkout:

Sermorelin, 2mg 1

FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Products are not for human consumption.

Description

Sermorelin is a synthetic peptide analog of naturally occurring growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to release growth hormone (GH) into the bloodstream by binding to specific receptors. The release of GH by sermorelin is pulsatile and regulated by the body’s natural processes, which helps avoid the side effects associated with other forms of GH therapy.

It has been studied for its potential use in treating growth hormone deficiency (GHD) in both children and adults, where it was found to increase GH and insulin-like growth factor-1 (IGF-1) levels in patients. In adults, it has been shown to increase muscle mass and decrease fat mass, as well as improve bone density and cognitive function.

Description

Sermorelin is a synthetic peptide analog of naturally occurring growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to release growth hormone (GH) into the bloodstream by binding to specific receptors. The release of GH by sermorelin is pulsatile and regulated by the body's natural processes, which helps avoid the side effects associated with other forms of GH therapy. It has been studied for its potential use in treating growth hormone deficiency (GHD) in both children and adults, where it was found to increase GH and insulin-like growth factor-1 (IGF-1) levels in patients. In adults, it has been shown to increase muscle mass and decrease fat mass, as well as improve bone density and cognitive function.

Properties

  • Chemical Formula : C149H246N44O42S
  • Synonyms : UNII-89243S03TE, 89243S03TE, Sermoreline, Sermorelinum, Growth Hormone Releasing Factor (GRF) (1-29) amide
  • Molar Mass : 3357.9 g/mol
  • CAS Number : 86168-78-7
  • PubChem : 16132413
  • Total Amount of the Active Ingredient : 2mg per vial
  • Shelf Life : 36 months

Sermorelin is a synthetic peptide analog of naturally occurring growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to release growth hormone (GH) into the bloodstream by binding to specific receptors. The release of GH by sermorelin is pulsatile and regulated by the body's natural processes, which helps avoid the side effects associated with other forms of GH therapy. It has been studied for its potential use in treating growth hormone deficiency (GHD) in both children and adults, where it was found to increase GH and insulin-like growth factor-1 (IGF-1) levels in patients. In adults, it has been shown to increase muscle mass and decrease fat mass, as well as improve bone density and cognitive function.

  • Chemical Formula : C149H246N44O42S
  • Synonyms : UNII-89243S03TE, 89243S03TE, Sermoreline, Sermorelinum, Growth Hormone Releasing Factor (GRF) (1-29) amide
  • Molar Mass : 3357.9 g/mol
  • CAS Number : 86168-78-7
  • PubChem : 16132413
  • Total Amount of the Active Ingredient : 2mg per vial
  • Shelf Life : 36 months
Sermorelin

Product Quality Guaranteed

All of our products are lab tested and the results are occasionally published on the website.

You can have the product you bought from us tested at any HPLC-licensed testing facility and if the results are negative, we will refund the following:

  • Cost of HPLC test
  • Total amount of the order + shipping fee

Peer-Reviewed Studies

A potentially effective drug for patients with recurrent glioma: sermorelin.

Chang, Y., Huang, R., Zhai, Y., Huang, L., Feng, Y., Wang, D., Chai, R., Zhang, W., & Hu, H. (2021).

Annals of translational medicine, 9(5), 406.

Selank and short peptides of the tuftsin family in the regulation of adaptive behavior in stress.

Kozlovskaya, M. M., Kozlovskii, I. I., Val'dman, E. A., & Seredenin, S. B. (2003).

Neuroscience and Behavioral Physiology, 33(9), 853-860.

Other Products Explore All

Explore All